ARTISAN (REM-PH-418) A Phase 4, Prospective, Multicenter, Single-Arm Study of a Mean Pulmonary Artery Pressure-Targeted Approach with Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Lung Biotechnology
Start Date
May 18, 2023
End Date
November 14, 2027
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Lung Biotechnology
Start Date
May 18, 2023
End Date
November 14, 2027